PS-341 and gemcitabine in patients with metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group (NCCTG) randomized phase II study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples